S
Salomon M. Stemmer
Researcher at Rabin Medical Center
Publications - 215
Citations - 12740
Salomon M. Stemmer is an academic researcher from Rabin Medical Center. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 43, co-authored 189 publications receiving 9651 citations. Previous affiliations of Salomon M. Stemmer include University of New South Wales & Tel Aviv University.
Papers
More filters
Journal ArticleDOI
Doctor-patient hierarchy may have a therapeutic role.
Dror Limon,Salomon M. Stemmer +1 more
TL;DR: Use of the title “Doctor” preserves hierarchy in a patient-doctor relationship, but hierarchy does not necessarily mean lack of respect, and deferential status exists in the patient- doctor relationship, regardless of whether this term is used.
Journal ArticleDOI
Ten-year clinical outcomes in >1000 node-negative (N0) Estrogen Receptor (ER)+ breast cancer (BC) patients (Pts) where treatment decisions incorporated the Recurrence Score Results: a registry analysis using TAILORx categorization
Salomon M. Stemmer,M. Leviov,Margarita Tokar,Noa Ben-Baruch,Beatrice Uziely,Georgeta Fried,Ora Rosengarten,A. Itay,Bella Nisenbaum,Steven Shak +9 more
Journal ArticleDOI
Palbociclib in combination with sunitinib exerts a synergistic anti-cancer effect in patient-derived xenograft models of various human cancers types.
Neta Moskovits,Idit Peretz,Eva Chausky,Ella Itzhaki,Nofar Shmuel,Raisa Meerson,Nataly Tarasenko,Aleksandr Kaufman,Amos Stemmer,Ranny Yaffe,Avital Bareket-Samish,Natalia Edison,Tal Goldman,Salomon M. Stemmer +13 more
TL;DR: In this paper , the authors evaluated the efficacy/safety of combining palbociclib (a CDK4/6 inhibitor) and sunitinib (a multi-targeted receptor tyrosine kinase inhibitor) using patient-derived xenograft (PDX) models.
Journal Article
[fertility preservation in young cancer patients - can we optimize the path?]
Irit Ben-Aharon,Shifra Ash,Avi Ben-Haroush,Gali Perl,Galia Oron,Haim Pinkas,Naphtali Freud,Dragan Kravarusic,Ronit Abir,Onit Sapir,Arnon Wiznitzer,Baruch Brenner,Isaac Yaniv,Salomon M. Stemmer,B Fisch +14 more
TL;DR: This program demonstrates that multidisciplinary programs that encompass relevant specialists, skilled laboratory resources and a facilitated path that drives the process in the shortest time, maximizes the yield.
Journal ArticleDOI
Tailoring neoadjuvant chemotherapy for locally advanced breast cancer: a historical prospective study.
Alona Zer,Shulamit Rizel,Rony Braunstein,Rinat Yerushalmi,Daniel Hendler,Victoria Neimann,Noa Cioreuru,Aaron Sulkes,Salomon M. Stemmer +8 more
TL;DR: A neoadjuvant regimen of doxorubicin with or without a sequential taxane, in which the number of cycles and the sequential administration of taxane are determined according to clinical response, appears to be safe and effective for patients with locally advanced breast cancer and yields a high rate of breast conservation.